Safety analysis of acyclovir use in neonates based on the FDA Adverse Event Reporting System
Acyclovir use in neonates may be associated with immune, gastrointestinal, hepatic, and renal AEs, underscoring the need for careful clinical monitoring, and further prospective studies are warranted to validate these associations.